Association of Antioxidant, Inflammatory, and Glycemic Status in Patients with Diabetic Foot Ulcers in Karachi, Pakistan: A Comparative Cross-Sectional Study
Abstract
To evaluate the association of antioxidant, inflammatory, and glycemic status in Patients with diabetic foot ulcers in Karachi, Pakistan.
A comparative cross-sectional study was conducted at the Department of Physiology in collaboration with the Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi, from June 2023 to June 2024. A total of 138 participants were enrolled and grouped into healthy controls, type 2 diabetics, and type 2 diabetics with foot ulcers. Type 1 diabetic patients were excluded. Glycemic parameters, including fasting blood glucose (FBG) and glycated hemoglobin (HbA1c), the oxidative stress marker superoxide dismutase (SOD), inflammatory biomarkers, including C-reactive protein (CRP), complete blood count parameters, and the neutrophil-to-lymphocyte ratio (NLR) were assessed. SOD was measured by ELISA, HbA1c by HPLC, and CRP by immunoturbidimetry. Statistical analysis was performed using IBM SPSS version 23.0.
Median FBG, HbA1c, SOD, CRP, TLC, neutrophil percentage, lymphocyte percentage, and NLR differed significantly among the three groups by applying the Kruskal–Wallis test, and Dunnett’s T3 post hoc analysis showed a significant difference (p < 0.001) in SOD levels among the three groups. HbA1c (OR=89.0; 95% CI:11.6–680), CRP (OR=1.08; 95% CI:1.02–1.13), and NLR (OR=1.86; 95% CI:1.28–2.71) were significant risk factors for DFU, whereas higher SOD levels (OR=0.87; 95% CI:0.84–0.91) showed a protective association by Multinomial logistic regression.
Poor glycemic control, increased systemic inflammation, and reduced antioxidant defense in DFU patients play a critical role in the development of foot ulcers in diabetic patients.
How to Cite This Article
Abro SU, Saleem Q, Tasneem U, Lashari J, Zahra B, Siddiqui RA. Association of Antioxidant, Inflammatory, and Glycemic Status in Patients with Diabetic Foot Ulcers in Karachi, Pakistan: A Comparative Cross-Sectional Study. J Pak Soc Intern Med. 2026;7(3):225–231. doi:10.70302/jpsim.v7i3.2643
Conflict of Interest
The authors declare no conflict of interest.
Funding
This research received no specific grant from any funding agency.
Funder information follows the Crossref Funder Registry standard.
References
- Wang Y, Shao T, Wang J, Huang X, Deng X, Cao Y, et al. An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage. Biomed Pharmacother. 2021;133(1):110991.
- Adnan SM, Fatima S, Hasan SM. Factors associated with diabetic foot ulceration among type 2 diabetes mellitus patients at Dow University Hospital, Karachi. Pak Biomed J. 2024;7(9):1-6.
- Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA, et al. Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(S1):e3266.
- Khan A, Junaid N. Prevalence of diabetic foot syndrome amongst population with type 2 diabetes in Pakistan in primary care settings. J Pak Med Assoc. 2017;67(12):1818-24.
- Lee SH, Kim SH, Kim KB, Kim HS, Lee YK. Factors influencing wound healing in diabetic foot patients. Medicina (Kaunas). 2024;60(5):723.
- Huma K, Mehboob K, Rashid A, Majeed A. Comparative analysis of superoxide dismutase-1 levels in diabetics with and without neuropathy. J Coll Physicians Surg Pak. 2021;31(7):765-9.
- Iacobini C, Vitale M, Pesce C, Pugliese G, Menini S. Diabetic complications and oxidative stress: A 20-year voyage back in time and back to the future. Antioxidants (Basel). 2021;10(5):727.
- Mohamed AA, Elmotaleb Hussein MA, Hanna IN, Nashwan AJJ, Saleh M, Abdel Wahed WY, et al. The potential impact and diagnostic value of inflammatory markers on diabetic foot progression in type II diabetes mellitus: A case-control study. Med Clin (Barc). 2024;162(9):e33-e39.
- Ulandari R, Kurniawan LB, Nurahmi N, Muhadi D. Analysis of neutrophil-to-lymphocyte ratio in type 2 diabetes mellitus patients with and without diabetic foot ulcers. Indones J Clin Pathol Med Lab. 2023;29(2):185-8.
- Wang X, Fu J, Li Q, Zeng D. Geographical and ethnic distributions of the MTHFR C677T, A1298C and MTRR A66G gene polymorphisms in Chinese populations: A meta-analysis. PLoS One. 2016;11(4):e0152414.
- Dean AG, Sullivan KM, Soe MM. OpenEpi: open source epidemiologic statistics for public health, version 2.3.1 [Internet]. Atlanta (GA): OpenEpi; 2010 [cited 2026 Jan 28]. Available from: [https://www.openepi.com]
- Vujčić S, et al. Oxidative stress and inflammatory biomarkers in patients with diabetic foot. Medicina (Kaunas). 2022;58(12):1866.
- Din N, Khan M, Khan BD, Ghaffar T, Ikram MT, Salman MA, Hadi NK, Khan S. Association of severity of diabetic foot ulcer with glycated hemoglobin A1C levels: Diabetic foot ulcer with glycated HBA1C levels. Pak J Health Sci. 2023;4(1):161-5.
- Wang J, Xue T, Li H, Guo S. Nomogram prediction for the risk of diabetic foot in patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2022;13(1):890057.
- Tang WH, Zhao YN, Cheng ZX, Xu JX, Zhang Y, Liu XM. Risk factors for diabetic foot ulcers: a systematic review and meta-analysis. Vascular. 2023;31(6):1095-105.
- Katya WE, Salman AN, Mohammed AG. Assessment of biochemical markers in diabetic foot ulcer patients at Thi-Qar province. Int J Health Sci (Qassim). 2022;6(S7):3614-20.
- Mossanda KS, Bolajoko EB, Moropane M, Adeniyi F, Akinosun O, Fasanmade A. Antioxidant and oxidative stress status in type 2 diabetes and diabetic foot ulcer. J Endocrinol Metab Diabetes S Afr. 2008;13(2):58-63.
- Vairamon SJ, John S, Kundu S. Oxidative stress markers regulating the healing of foot ulcers in patients with type 2 diabetes. Wounds. 2009;21(10):273-9.
- Bolajoko EB, Akinosun OM, Anetor JI, Mossanda KS. Relationship between selected micronutrient deficiencies and oxidative stress biomarkers in diabetes mellitus patients with foot ulcers in Ibadan, Nigeria. Turk J Med Sci. 2017;47(4):479-86.
- Lin CC, Hsu LA, Chen CC, Yeh JI, Sun JH, Lin CH, et al. C-reactive protein as an outcome predictor for percutaneous transluminal angioplasty in diabetic patients with peripheral arterial disease and infected foot ulcers. Diabetes Res Clin Pract. 2010;90(2):167-72.
- Stanimirovic J, Radovanovic J, Banjac K, Obradovic M, Essack M, Zafirovic S, et al. Role of C-reactive protein in diabetic inflammation. Mediators Inflamm. 2022;doi:10.1155/2022/3706508. doi:10.1155/2022/3706508
- Asher F, Daraie M, Mohammadi F. Neutrophil-to-lymphocyte ratio as a predictor of diabetic foot ulcer amputation. BMC Endocr Disord. 2025; doi:10.1186/s12902-025-01941-0. doi:10.1186/s12902-025-01941-0
- Zia Ur Rehman, Shaikh H, Bachani F. Predictive value of neutrophil-to-lymphocyte ratio in diabetic foot ulcer outcomes. J Pak Med Assoc. 2024;74(12):2096-100.
- Noor HT, Butt NF, Latif H, Rathore R, Bangash AF, Iqbal A. Study of platelet-to-lymphocyte ratio as a predictor inflammatory marker for diabetic nephropathy in patients with type 2 diabetes mellitus. J Pak Soc Intern Med. 2025;6(1):16-21.
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.